Pharmaceutical bulletins

Regional experts urge collaboration to advance the management of inflammatory bowel diseases in Lebanon

Regional experts urge collaboration to advance the management of inflammatory bowel diseases in Lebanon

Lebanon, Beirut, 6th March 2019: More than 125 gastroenterologists, hepatologists and internal medicine specialists gathered recently at the first Middle East Inflammatory Bowel Disease (IBD) summit, which was held in the United Arab Emirates (UAE). The two-day event was organized by Takeda Pharmaceuticals, one of the world’s leading biopharmaceutical companies, focused on the impact of

“TRINOMIA POLYPILL, AN ESSENTIAL TREATMENT FOR CARDIOVASCULAR PREVENTION”

  A group of experts will discuss today the last evidence about the polypill benefits Beirut, January 30th – Cardiovascular diseases are the main cause of death worldwide and they are responsible for half of all deaths in Lebanon. Thus, controlling cardiovascular risk factors is essential for patients. Despite the established efficacy of cardiovascular medications, suboptimal

Top